Skip to content

Cognitive therapy may improve quality of life in people with acromegaly

Think healthy: contributions of cognitive therapy to increase the quality of life in patients with acromegaly

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6p2vsf
Enrollment
Unknown
Registered
2018-10-01
Start date
2015-08-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acromegaly and Giant Pituitary

Interventions

Intervention group: 10 patients with agromegaly were followed in 12 weekly sessions of psychotherapy in a group focused on the improvement of quality of life. The steps included the evaluation of diff
decision-making for quality of life
weekly monitoring of planned activities
the daily launch of healthy behaviors
the approach of difficulties - depression, insomnia, social interaction ability and body image
cognitive preparation for behavioral experiments
the use of images and metaphors in cognitive therapy
the construction of reflection thinking and coping cards and the evaluation of the results of group intervention. Control group: 13 patients with agromegaly received the same treatment protocol that i
Behavioural

Sponsors

Faculdade de Ciências da Saúde da Universidade de Brasília
Lead Sponsor
Faculdade de Ciências da Saúde da Universidade de Brasília
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: The criteria for inclusion in the group are patients with acromegaly in ambulatory follow-up, of both gender, aged between 18 and 70 years, with intellectual capacity to follow the intervention and who agree to participate in the study.

Exclusion criteria

Exclusion criteria: There are criteria for excluding the sample: suicide risk; absence of commitment to the fulfillment of written tasks and being accompanied in therapy. Sample participants shall be considered as sample loss if they are absent, not justified, for two consecutive sessions or for three alternating sessions.

Design outcomes

Primary

MeasureTime frame
It was expected that the patients in the intervention group had an increase in quality of life indexes, evaluated by SF36, in comparison with the beginning of the study and in relation to the control group. Immediately after the end of the intervention and that it remains the best in the evaluation of 9 months.;There was an improvement in the quality of life indicators related to the mental health of the intervention group, the mental health related dimension of the SF36 had an increase of 23.87% in the mean of the intervention group.

Secondary

MeasureTime frame
Not expected.

Countries

Brazil

Contacts

Public ContactLia Kunzler

Faculdade de Ciências da Saúde da Universidade de Brasília

lia.kunzler@gmail.com55-061-31071947

Outcome results

None listed

Source: REBEC (via WHO ICTRP)